Nomura Phase4 Ventures Lp - Net Worth and Insider Trading

Nomura Phase4 Ventures Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nomura Phase4 Ventures Lp owns 2 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) , and Catalyst Biosciences Inc (CBIO) .

Click here to see the complete history of Nomura Phase4 Ventures Lp’s form 4 insider trades.

Insider Ownership Summary of Nomura Phase4 Ventures Lp

Ticker	Comapny	Transaction Date	Type of Owner
ACAD	ACADIA Pharmaceuticals Inc	2005-08-18	10 percent owner & other: Member of 13G Group (1)
CBIO	Catalyst Biosciences Inc	2006-04-11	10 percent owner & other: Member of 13G Group

Nomura Phase4 Ventures Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nomura Phase4 Ventures Lp Ownership Network

Ownership Network List of Nomura Phase4 Ventures Lp

No Data

Ownership Network Relation of Nomura Phase4 Ventures Lp

Nomura Phase4 Ventures Lp Owned Company Details

What does ACADIA Pharmaceuticals Inc do?

Who are the key executives at ACADIA Pharmaceuticals Inc?

Nomura Phase4 Ventures Lp is the 10 percent owner & other: Member of 13G Group (1) of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .

ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary

Over the past 18 months, Nomura Phase4 Ventures Lp made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .

In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

ACADIA Pharmaceuticals Inc Insider Transactions

No Available Data

Nomura Phase4 Ventures Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Nomura Phase4 Ventures Lp. You might contact Nomura Phase4 Ventures Lp via mailing address: Nomura House, 1 St Martin's-le-grand, London X0 Ec1a 4np.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.